Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Rises By 169.0%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 15,600 shares, an increase of 169.0% from the March 31st total of 5,800 shares. Based on an average daily trading volume, of 300 shares, the days-to-cover ratio is currently 52.0 days.

Santhera Pharmaceuticals Stock Performance

Shares of OTCMKTS:SPHDF remained flat at $17.54 on Monday. The stock has a 50-day moving average of $14.67 and a two-hundred day moving average of $11.86. Santhera Pharmaceuticals has a twelve month low of $16.00 and a twelve month high of $17.54.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).